California State Teachers Retirement System (CalSTRS)’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-58,388
| Closed | -$1.95M | – | 3071 |
|
|
2026
Q1 | $1.95M | Buy |
58,388
+17,671
| +43% | +$693K | ﹤0.01% | 1535 |
|
|
2025
Q4 | $1.89M | Buy |
40,717
+8,789
| +28% | +$482K | ﹤0.01% | 1448 |
|
|
2025
Q3 | $2.16M | Buy |
31,928
+2
| +0% | +$148 | ﹤0.01% | 1363 |
|
|
2025
Q2 | $2.67M | Buy |
31,926
+632
| +2% | +$47.3K | ﹤0.01% | 1220 |
|
|
2025
Q1 | $2.24M | Buy |
31,294
+9,317
| +42% | +$454K | ﹤0.01% | 1279 |
|
|
2024
Q4 | $988K | Buy |
21,977
+4,201
| +24% | +$218K | ﹤0.01% | 1784 |
|
|
2024
Q3 | $898K | Buy |
17,776
+2,949
| +20% | +$141K | ﹤0.01% | 1848 |
|
|
2024
Q2 | $605K | Buy |
14,827
+1,047
| +8% | +$44.4K | ﹤0.01% | 2007 |
|
|
2024
Q1 | $590K | Buy |
13,780
+3,481
| +34% | +$157K | ﹤0.01% | 2069 |
|
|
2023
Q4 | $415K | Buy |
+10,299
| New | +$293K | ﹤0.01% | 2301 |
|
|
2021
Q2 | – | Sell |
-6,009
| Closed | -$114K | – | 3228 |
|
|
2021
Q1 | $114K | Hold |
6,009
| – | – | ﹤0.01% | 3025 |
|
|
2020
Q4 | $174K | Hold |
6,009
| – | – | ﹤0.01% | 2893 |
|
|
2020
Q3 | $226K | Buy |
6,009
+2,647
| +79% | +$77.4K | ﹤0.01% | 2670 |
|
|
2020
Q2 | $112K | Buy |
+3,362
| New | +$146K | ﹤0.01% | 2927 |
|
California State Teachers Retirement System (CalSTRS)'s SLNO Position: Q2 2026 in Review
California State Teachers Retirement System (CalSTRS) sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 58,388 shares — an estimated $1.95M sold.
California State Teachers Retirement System (CalSTRS) first reported a position in SLNO in Q2 2020 and held it in 14 quarters. The position peaked at $2.67M in Q2 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.
- California State Teachers Retirement System (CalSTRS) reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
- California State Teachers Retirement System (CalSTRS) sold 58,388 Soleno Therapeutics shares in Q2 2026, an estimated $1.95M.
- California State Teachers Retirement System (CalSTRS) first reported a position in Soleno Therapeutics in Q2 2020 and held it in 14 quarters.
- California State Teachers Retirement System (CalSTRS)'s Soleno Therapeutics position peaked at $2.67M in Q2 2025.
- 0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.